Tan Justin Hong-Jie, Scheinman Melvin M
School of Medicine, University of California San Francisco, San Francisco, California, USA.
Am J Cardiol. 2008 Apr 15;101(8):1142-6. doi: 10.1016/j.amjcard.2007.11.066. Epub 2008 Feb 11.
Patients with catecholaminergic polymorphic ventricular tachycardia present at a young age with exercise-induced ventricular arrhythmias (VAs) and may have a positive family history. We describe 8 patients who presented with exercise-induced symptoms as adults, have a negative family history, and responded to beta-blocker therapy. The study evaluated exercise treadmill electrocardiographic data from patients referred for exercise-induced VA. Inclusion criteria consisted of development of bidirectional, pleomorphic, or polymorphic ventricular tachycardia with exercise, adult age at first onset, negative family history, and no evidence of structural heart disease. We correlated VA configurations with respect to heart rate before and after beta-blocker therapy. Patients displayed a pattern of increasing ventricular complexity with increasing heart rate. The appropriate beta blocker (n = 7) or calcium channel blocker (n = 1) was defined as the dose that resulted in control of symptoms. Three patients showed suppression of VA with sinus tachycardia at peak heart rate. Six patients had decreased VA defined as absence of higher complexity arrhythmias. With drug therapy, average heart rate associated with premature ventricular complex couplets/triplets increased, whereas duration and complexity of premature ventricular complexes decreased. One patient had an automatic implantable cardiac defibrillator placed but has had no discharges from the device since starting the appropriate beta blocker. In conclusion, these patients appear to respond well to beta-blocker or calcium channel blocker therapy with decreased ectopic complexity and an increased heart rate threshold for inducing VA.
儿茶酚胺能多形性室性心动过速患者发病年龄较轻,有运动诱发的室性心律失常(VA),且可能有家族史阳性。我们描述了8例成年后出现运动诱发症状、家族史阴性且对β受体阻滞剂治疗有反应的患者。该研究评估了因运动诱发VA而转诊患者的运动平板心电图数据。纳入标准包括运动时出现双向、多形性或多形性室性心动过速、首次发病年龄为成人、家族史阴性且无结构性心脏病证据。我们比较了β受体阻滞剂治疗前后VA形态与心率的关系。患者表现出随着心率增加室性复杂性增加的模式。将合适的β受体阻滞剂(n = 7)或钙通道阻滞剂(n = 1)定义为能控制症状的剂量。3例患者在心率峰值时窦性心动过速时VA受到抑制。6例患者的VA减少,定义为无更高复杂性心律失常。药物治疗后,与室性早搏成对/成三联律相关的平均心率增加,而室性早搏的持续时间和复杂性降低。1例患者植入了自动植入式心脏除颤器,但自开始使用合适的β受体阻滞剂以来该装置未放电。总之,这些患者似乎对β受体阻滞剂或钙通道阻滞剂治疗反应良好,异位复杂性降低,诱发VA的心率阈值增加。